Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| ALVO | NASDAQ | Alvotech | $5.29 | +0.95% | 668K | $1.79B |
| LKFT | NASDAQ | Lakefront Biotherapeutics N.V. | $26.81 | +0.20% | 246K | $1.77B |
| SEPN | NASDAQ | Septerna Inc | $38.51 | +2.01% | 354K | $1.74B |
| PSNL | NASDAQ | Personalis, Inc. | $16.21 | -0.73% | 1.4M | $1.73B |
| DMRA | NASDAQ | Damora Therapeutics, Inc. | $28.10 | +4.69% | 525K | $1.73B |
| BLFS | NASDAQ | BioLife Solutions, Inc. | $34.95 | +0.09% | 863K | $1.71B |
| RXRX | NASDAQ | Recursion Pharmaceuticals, Inc. | $3.20 | +1.27% | 8M | $1.68B |
| IMCR | NASDAQ | Immunocore Holdings plc | $32.60 | -2.92% | 314K | $1.66B |
| KARD | NASDAQ | Kardigan, Inc. | $18.52 | -0.91% | 416K | $1.65B |
| NTLA | NASDAQ | Intellia Therapeutics, Inc. | $11.74 | -1.59% | 2.7M | $1.64B |
| FTRE | NASDAQ | Fortrea Holdings Inc. | $17.20 | +1.06% | 926K | $1.64B |
| ATEC | NASDAQ | Alphatec Holdings, Inc. | $10.58 | +19.68% | 6.5M | $1.63B |
| SNDX | NASDAQ | Syndax Pharmaceuticals, Inc. | $18.18 | -3.40% | 1.2M | $1.61B |
| TSHA | NASDAQ | Taysha Gene Therapies, Inc. | $5.02 | -2.71% | 1.8M | $1.61B |
| INBX | NASDAQ | Inhibrx Biosciences Inc. | $109.27 | -1.93% | 211K | $1.6B |
| ANIP | NASDAQ | ANI Pharmaceuticals, Inc. | $70.19 | -1.78% | 329K | $1.6B |
| ANAB | NASDAQ | AnaptysBio, Inc. | $53.87 | -2.34% | 336K | $1.6B |
| ETON | NASDAQ | Eton Pharmaceuticals, Inc. | $57.08 | -1.38% | 323K | $1.56B |
| NVAX | NASDAQ | Novavax, Inc. | $9.42 | +1.29% | 6.1M | $1.55B |
| INVA | NASDAQ | Innoviva, Inc. | $20.66 | +0.19% | 503K | $1.52B |
| DRTSW | NASDAQ | Alpha Tau Medical Ltd. | $3.93 | -1.75% | 17K | $1.52B |
| HCSG | NASDAQ | Healthcare Services Group, Inc. | $21.98 | +0.64% | 549K | $1.51B |
| BCAX | NASDAQ | Bicara Therapeutics Inc. Common Stock | $22.81 | -1.26% | 450K | $1.5B |
| AAPG | NASDAQ | Ascentage Pharma Group International | $16.10 | -3.48% | 7K | $1.5B |
| OMCL | NASDAQ | Omnicell, Inc. | $32.79 | +1.67% | 484K | $1.49B |
| AVLN | NASDAQ | Avalyn Pharma Inc. Common Stock | $33.57 | -3.17% | 133K | $1.49B |
| INNV | NASDAQ | Innovage Holding Corp. | $10.75 | +1.42% | 190K | $1.46B |
| PAHC | NASDAQ | Phibro Animal Health Corporation | $35.62 | -2.62% | 212K | $1.44B |
| AZTA | NASDAQ | Azenta, Inc. | $30.85 | +2.22% | 736K | $1.42B |
| RARE | NASDAQ | Ultragenyx Pharmaceutical Inc. | $14.30 | -0.69% | 3.3M | $1.41B |
| ABSI | NASDAQ | Absci Corporation | $8.21 | -0.36% | 2M | $1.39B |
| NUTX | NASDAQ | Nutex Health, Inc. | $200.24 | +2.58% | 137K | $1.38B |
| PNTG | NASDAQ | The Pennant Group, Inc. | $39.20 | -0.25% | 168K | $1.36B |
| MAZE | NASDAQ | Maze Therapeutics, Inc. | $24.60 | -0.89% | 1.1M | $1.36B |
| AVBP | NASDAQ | ArriVent BioPharma, Inc. | $29.00 | +1.05% | 1.1M | $1.35B |
| KMTS | NASDAQ | Kestra Medical Technologies, Ltd. | $22.85 | -3.05% | 242K | $1.34B |
| LTGO | NASDAQ | Latigo Biotherapeutics Inc. | $22.15 | +2.83% | 179K | $1.33B |
| OMER | NASDAQ | Omeros Corporation | $18.28 | -1.67% | 1M | $1.32B |
| TYRA | NASDAQ | Tyra Biosciences, Inc. | $22.03 | -6.41% | 1.5M | $1.31B |
| DRTS | NASDAQ | Alpha Tau Medical Ltd | $14.43 | -0.07% | 405K | $1.3B |
| XERS | NASDAQ | Xeris Biopharma Holdings, Inc. | $7.45 | -2.87% | 1.6M | $1.29B |
| HROW | NASDAQ | Harrow Health, Inc. | $34.48 | -5.74% | 987K | $1.29B |
| LBRX | NASDAQ | LB Pharmaceuticals Inc Common Stock | $44.63 | -3.50% | 208K | $1.28B |
| TRAX | NASDAQ | First Tracks Biotherapeutics Inc | $36.44 | -4.05% | 620K | $1.27B |
| CGEM | NASDAQ | Cullinan Therapeutics, Inc. | $20.59 | -1.95% | 1.1M | $1.27B |
| SPTX | NASDAQ | Seaport Therapeutics, Inc. Common Stock | $23.34 | +0.26% | 134K | $1.25B |
| ORIC | NASDAQ | ORIC Pharmaceuticals, Inc. | $12.04 | -0.25% | 1.1M | $1.25B |
| AKTS | NASDAQ | Aktis Oncology, Inc. | $23.30 | -2.67% | 229K | $1.24B |
| VOR | NASDAQ | Vor Biopharma Inc. | $22.30 | -0.18% | 800K | $1.21B |
| IART | NASDAQ | Integra LifeSciences Holdings Corporation | $15.50 | -0.26% | 792K | $1.21B |
50 Healthcare Companies
Review companies currently returned for the Healthcare screen, with price, performance, volume and market-cap context.
How This Sector Screen Works
Results are loaded from current company data and can be narrowed by exchange or company search without changing the canonical sector page.
About the Healthcare Sector
The Healthcare classification groups companies with related business activities so investors can compare peers within a common market segment.
Related Sector Screens
Return to the screener directory to compare this sector with daily movers and the other industry groups covered by Cashu Finance.